Report cover image

Canadian Human Cadaveric Tissue Market

Publisher Grand View Research
Published Feb 23, 2026
Length 120 Pages
SKU # GV21005697

Description

Size, Share & Trends Analysis Report By Product (Soft Tissue Allografts, Musculoskeletal Allografts, Bone Allografts, Cardiovascular), By Indication, By End Use, By Source Of Supply, And Segment Forecasts, 2026 - 2033

Canadian Human Cadaveric Tissue Market Summary

The Canadian human cadaveric tissue market size was valued at USD 129.50 million in 2025 and is anticipated to reach USD 212.74 million by 2033, expanding at a CAGR of 6.55% from 2026 to 2033. This growth is attributed to the rising number of orthopedic, spinal, and dental procedures requiring biological graft materials.

An aging population and the increasing prevalence of musculoskeletal disorders are further boosting demand for bone and soft-tissue reconstruction. Growing preference for biologic reconstruction over synthetic alternatives also supports market expansion. In addition, advancements in tissue processing and preservation technologies are enhancing graft safety and clinical outcomes, strengthening adoption across surgical applications.

The increasing number of surgical procedures in Canada is a major driver of the human cadaveric tissue market. Rising volumes of orthopedic, spinal, dental, and reconstructive surgeries are driving sustained demand for bone and soft-tissue grafts. Allografts are widely used to restore structural support, promote healing, and reduce donor-site complications associated with autografts. As surgical capacity expands and waits times are addressed, utilization of cadaveric tissue products continues to grow.

Canadian Human Cadaveric Tissue Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the Canadian human cadaveric tissue market report on the basis of product, indication, end use and source of supply:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Soft Tissue Allografts
  • Cadaveric skin
  • Acellular Dermal Matrix (ADM)
  • Musculoskeletal Allografts
  • Bone Allografts
  • Demineralized Bone Matrix (DBM)
  • Others
  • Cardiovascular
  • Heart Valves
  • Vascular Grafts
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Burn Care & Wound Reconstruction
  • Plastic & Reconstructive Surgery
  • Orthopedic Surgery (Spine, Trauma, Sports Medicine)
  • Dental
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • In-Hospital Procedures
  • Out-of-Hospital Settings
  • Source of Supply Outlook (Revenue, USD Million, 2021 - 2033)
  • Domestic Cadaveric Tissue
  • Imported Cadaveric Tissue
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Indication
1.1.3. End Use
1.1.4. Source of Supply
1.1.5. Estimates And Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details Of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Price Analysis (Model 1)
1.6.2. Approach 1: Commodity Flow Approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Canadian Human Cadaveric Tissue Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising surgical volume trends
3.2.1.2. Increasing aging population
3.2.1.3. Rising preference for biologic reconstruction and advancements in allograft innovation
3.2.1.4. Growth in orthopedic & reconstructive procedures
3.2.2. Market Restraint Analysis
3.2.2.1. Regulatory complexity and compliance burden
3.2.2.2. Dependence on imports
3.2.2.3. Controlled import rules that add friction
3.2.3. Market Opportunity Analysis
3.2.3.1. Shift toward processed & value-added allografts
3.2.3.2. Government driven policy enhancements & strategic initiatives
3.2.3.3. Advancements in tissue processing & preservation
3.2.3.4. Increasing number of clinical trials
3.2.3.5. Technological advancements
3.2.4. Market Challenge Analysis
3.2.4.1. Limited domestic processing capacity
3.2.4.2. Variable consent/authorization systems and donation rates
3.3. Canadian Human Cadaveric Tissue Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Canadian Human Cadaveric Tissue Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Canadian Human Cadaveric Tissue Market Product Movement Analysis
4.3. Canadian Human Cadaveric Tissue Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
4.4. Soft Tissue Allografts
4.4.1. Soft Tissue Allografts Market Estimates and Forecasts for 2021 to 2033 (USD Million)
4.4.2. Cadaveric skin
4.4.2.1. Cadaveric skin market Estimates and Forecasts for 2021 to 2033 (USD Million)
4.4.3. Acellular dermal matrix (ADM)
4.4.3.1. Acellular dermal matrix (ADM) market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Musculoskeletal Allografts
4.5.1. Musculoskeletal Allografts Market Estimates and Forecasts for 2021 to 2033 (USD Million)
4.6. Bone Allografts
4.6.1. Bone Allografts Market Estimates and Forecasts for 2021 to 2033 (USD Million)
4.6.2. Demineralized Bone Matrix (DBM)
4.6.2.1. Demineralized Bone Matrix (DBM) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
4.6.3. Others
4.6.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
4.7. Cardiovascular
4.7.1. Cardiovascular Market Estimates and Forecasts for 2021 to 2033 (USD Million)
4.7.2. Heart Valves
4.7.2.1. Heart valves market estimates and forecasts for 2021 to 2033 (USD Million)
4.7.3. Vascular Grafts
4.7.3.1. Vascular grafts market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. Canadian Human Cadaveric Tissue Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Canadian Human Cadaveric Tissue Market Indication Movement Analysis
5.3. Canadian Human Cadaveric Tissue Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
5.4. Burn Care & Wound Reconstruction
5.4.1. Burn Care & Wound Reconstruction Market Estimates and Forecasts for 2021 to 2033 (USD Million)
5.5. Plastic & Reconstructive Surgery
5.5.1. Plastic & Reconstructive Surgery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
5.6. Orthopedic Surgery
5.6.1. Orthopedic Surgery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
5.7. Dental
5.7.1. Dental Market Estimates and Forecasts for 2021 to 2033 (USD Million)
5.8. Others
5.8.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)
Chapter 6. Canadian Human Cadaveric Tissue Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Canadian Human Cadaveric Tissue Market End Use Movement Analysis
6.3. Canadian Human Cadaveric Tissue Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
6.4. In-Hospital Procedures
6.4.1. In-Hospital Procedures Market Estimates and Forecasts for 2021 to 2033 (USD Million)
6.5. Out-of-Hospital Settings
6.5.1. Out-of-Hospital Settings Market Estimates and Forecasts for 2021 to 2033 (USD Million)
Chapter 7. Canadian Human Cadaveric Tissue Market: Source of Supply Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Canadian Human Cadaveric Tissue Market Source of Supply Movement Analysis
7.3. Canadian Human Cadaveric Tissue Market Size & Trend Analysis, by Source of Supply 2021 to 2033 (USD Million)
7.4. Domestic Cadaveric Tissue
7.4.1. Domestic Cadaveric Tissue Market Estimates and Forecasts for 2021 to 2033 (USD Million)
7.5. Imported Cadaveric Tissue
7.5.1. Imported Cadaveric Tissue Market Estimates and Forecasts for 2021 to 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. Key company market share analysis, 2025
8.3.2. MTF Biologics
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Usage benchmarking
8.3.2.4. Strategic initiatives
8.3.3. LifeNet Health
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Usage benchmarking
8.3.3.4. Strategic initiatives
8.3.4. AlloSource
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Usage benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Artivion (formerly CryoLife)
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Usage benchmarking
8.3.5.4. Strategic initiatives
8.3.6. LeMaitre
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Usage benchmarking
8.3.6.4. Strategic initiatives
8.3.7. AlloWide Health Inc.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Usage benchmarking
8.3.7.4. Strategic initiatives
8.3.8. BioHorizons (Henry Schein, Inc.)
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Usage benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Zimmer Biomet
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Usage benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Medtronic
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Usage benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Stryker
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Usage benchmarking
8.3.11.4. Strategic initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us